Cardioprotective activity of mibefradil.
van Zwieten
P A
PA
D000818:Animals; D001562:Benzimidazoles / Q000737:chemistry / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000737:chemistry / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D020748:Mibefradil; D009203:Myocardial Infarction / Q000517:prevention & control*; D051381:Rats; D012008:Recurrence; D013764:Tetrahydronaphthalenes / Q000737:chemistry / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000737:chemistry / Q000627:therapeutic use*
D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D013764:Tetrahydronaphthalenes; D014665:Vasodilator Agents; D020748:Mibefradil